Regeneron Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic ma…

Biotechnology
US, Tarrytown [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Regeneron Pharmaceuticals, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of REGN's Analysis
CIK: 872589 CUSIP: 75886F107 ISIN: US75886F1075 LEI: - UEI: -
Secondary Listings
REGN has no secondary listings inside our databases.